ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

YCBD vs BYAH // EV/EBITDA & P/E VALUATION

cbdMD Inc. (NYSE) VS. Park Ha Biological Technology Co. Ltd. (Class A) (NASDAQ) • 15-METRIC TALLY: YCBD 3 — BYAH 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (YCBD VS. BYAH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC YCBD BYAH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.40% 94.40% -32.00 BYAH /gross-margins <GO>
Return on Invested Capital (ROIC) -30.40% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — 1.09% — TIE /fcf-yield <GO>
Operating Margin -11.30% -60.00% +48.70 YCBD /operating-margins <GO>
Net Profit Margin -10.60% -60.00% +49.40 YCBD /net-margins <GO>
Revenue Growth (YoY) -1.50% 6.00% -7.50 BYAH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 BYAH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 42.3 +1.81 YCBD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.3M $7.9M -$3.5M BYAH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR YCBD REV BYAH REV YCBD GROSS % BYAH GROSS % YCBD FCF BYAH FCF
FY 2025 $19.2M $2.5M 62.4% 94.4% -$1.6M $85.9K
FY 2024 $19.5M $2.4M 61.6% 91.8% -$542.8K $960.5K
FY 2023 $24.2M $2.5M — — -$4.3M $126.5K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
YCBD // BETA —
BYAH // BETA —